BioSpace News Archive

Job Trends

NMI® at 60.7%; November Non-Manufacturing ISM® Report On Business®

Business Activity Index at 65.2%; New Orders Index at 62.5%; Employment Index at 58.4%

December 6, 2018
·
23 min read
Lone Star Bio

Parker Family Receives Daily Point of Light Award for Work with Mercy Ships

Focused on the global surgery crisis, family dedicates decades to volunteer on ship in Africa

December 6, 2018
·
5 min read
Business

BioSurplus Appoints Shelley Amster to Its Board of Directors

Shelley Amster has worked in the life science and health industries for more than 30 years, beginning with her research on infertility.

December 6, 2018
·
1 min read
Business

Healogics Wound Science Initiative Addresses Social Determinants of Health

New research analyzes correlation between social and environmental conditions and health outcomes

December 6, 2018
·
3 min read
FDA

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products

One challenge we face right now, when it comes to developing diagnostics that can help target the delivery of cancer drugs, is the way these diagnostics are sometimes labeled.

December 6, 2018
·
6 min read
Biotech Bay

Regal Medical Group Reminds 2018 Medicare Open Enrollment Period Coming to a Close December 7

The 2018 Medicare Open Enrollment Period will end on December 7, 2018. Eligible Medicare beneficiaries interested in obtaining coverage for the first time or enrolling in a different health plan have until tomorrow to finalize their health insurance for 2019.

December 6, 2018
·
1 min read
Drug Development

Novartis investigational BYL719 (alpelisib) plus fulvestrant consistently improved PFS in patients with PIK3CA mutated HR+/HER2- advanced breast cancer in new SOLAR-1 analyses

BYL719 plus fulvestrant meaningfully prolonged PFS vs fulvestrant alone in patients with PIK3CA mutated HR+/HER2- advanced breast cancer after progression on an aromatase inhibitor or after receiving up to one additional line of therapy1

December 6, 2018
·
10 min read
Bio NC

Significant Enhancements Announced for Pathway, VeraSci’s Proprietary eCOA Platform

VeraSci, a global clinical technology and research services company, announces multiple significant enhancements to Pathway, their proprietary eCOA platform.

December 6, 2018
·
2 min read
Job Trends

Honda R&D Americas Announces Expansion in Raymond, Ohio

Investment Grows Honda’s Second-Largest R&D Center Worldwide

December 6, 2018
·
2 min read
Business

CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing

The partners will utilize their IP, expertise, and know-how to offer the first system enabling ultra-high resolution bioprinting of microstructures such as vascular networks or capillaries.

December 6, 2018
·
3 min read